| Spirig HealthCare AG - Oxycodon Naloxon Spirig HC 30 mg/15 mg, Retardtabletten | | 65931 | | 04 | | Oxycodon Naloxon Spirig HC 30 mg/15 mg | | Retardtabletten | | N02AA55 | | Oxycodone and Naloxone | | 16.03.2017 | | |
| | Zusammensetzung | | oxycodoni hydrochloridum 30 mg, naloxoni hydrochloridum anhydricum 15 mg ut naloxoni hydrochloridum dihydricum, poly(vinylis acetas), povidonum K 27-32, natrii laurilsulfas, cellulosum microcristallinum, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), talcum, macrogolum 3350, E 171, E 172 (flavum), pro compresso obducto corresp. natrium 0.05 mg. | | Packungsbestandteile | | Retard-Tabletten | | | | Wirkstoffe | Stärke |
|---|
| Naloxoni Hydrochloridum Anhydricum | 15 mg | | Oxycodone Hydrochloride | 30 mg |
| | | | Hilfsstoffe | Stärke | Zusätzliche Information |
|---|
| (Flavum) | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | E 172 | | color. | | Macrogolum | 3350 | | | Magnesii Stearas | | | | Natrii Laurilsulfas | | | | Poly(Alcohol Vinylicus) | | Überzug | | Poly(Vinylis Acetas) | | | | Povidonum K | 27-32 | | | Pro Compresso Obducto | | | | Silica Colloidalis Anhydrica | | | | Talcum | | |
|
| | Packungsnummer | Packungsgrösse | EFP | PP | Kat. | SL | In Refdata nicht gelistet |
|---|
| 017 | 30 | PA | PA | A+ | | Ja | | 018 | 60 | PA | PA | A+ | | Ja |
|
|
